IRIS
PICARDI, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 29.810
EU - Europa 3.211
AS - Asia 3.049
SA - Sud America 486
Continente sconosciuto - Info sul continente non disponibili 276
AF - Africa 51
OC - Oceania 5
Totale 36.888
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.531
SG - Singapore 1.385
DE - Germania 869
CN - Cina 669
RU - Federazione Russa 405
IT - Italia 393
BR - Brasile 383
UA - Ucraina 381
IE - Irlanda 293
GB - Regno Unito 277
VN - Vietnam 254
HK - Hong Kong 240
CA - Canada 185
FR - Francia 163
FI - Finlandia 125
SE - Svezia 121
BD - Bangladesh 110
KR - Corea 100
JP - Giappone 77
PL - Polonia 66
IN - India 47
AR - Argentina 41
MX - Messico 26
IQ - Iraq 24
NL - Olanda 24
CR - Costa Rica 23
UZ - Uzbekistan 22
ZA - Sudafrica 20
ES - Italia 18
EC - Ecuador 17
ID - Indonesia 16
JM - Giamaica 16
AT - Austria 14
BE - Belgio 13
PK - Pakistan 13
CL - Cile 11
CO - Colombia 10
CZ - Repubblica Ceca 10
PH - Filippine 10
SA - Arabia Saudita 10
MY - Malesia 9
AE - Emirati Arabi Uniti 8
TR - Turchia 8
IR - Iran 7
NI - Nicaragua 7
KG - Kirghizistan 6
PY - Paraguay 6
VE - Venezuela 6
AU - Australia 5
CH - Svizzera 5
EU - Europa 5
GT - Guatemala 5
HN - Honduras 5
IL - Israele 5
PE - Perù 5
UY - Uruguay 5
BG - Bulgaria 4
DK - Danimarca 4
EG - Egitto 4
GR - Grecia 4
LT - Lituania 4
NP - Nepal 4
RO - Romania 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
DZ - Algeria 3
EE - Estonia 3
ET - Etiopia 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
MA - Marocco 3
NG - Nigeria 3
TH - Thailandia 3
TN - Tunisia 3
TW - Taiwan 3
AO - Angola 2
AZ - Azerbaigian 2
BH - Bahrain 2
CG - Congo 2
HU - Ungheria 2
LB - Libano 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
AI - Anguilla 1
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
CW - ???statistics.table.value.countryCode.CW??? 1
DM - Dominica 1
GM - Gambi 1
GY - Guiana 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
LY - Libia 1
Totale 36.610
Salva come PNG Salva come JPEG
Città #
Woodbridge 7.789
Wilmington 7.525
Houston 6.616
Fairfield 814
Ashburn 804
Ann Arbor 717
Singapore 671
Chandler 472
San Jose 440
Seattle 342
Jacksonville 313
Cambridge 275
Dublin 264
Beijing 255
Hong Kong 239
Medford 205
Dearborn 192
Munich 161
New York 160
Rome 137
Council Bluffs 130
Santa Clara 123
Mcallen 112
Montréal 110
Los Angeles 102
Lawrence 98
The Dalles 92
Zhengzhou 86
Dallas 85
Ho Chi Minh City 73
Moscow 66
Lauterbourg 64
Tokyo 62
Helsinki 56
Hanoi 55
Buffalo 50
Kraków 45
San Diego 43
São Paulo 43
Menlo Park 35
Orem 35
Mülheim 32
Milan 31
Chicago 28
London 26
Toronto 26
Denver 25
Redondo Beach 23
San José 22
Boardman 20
Frankfurt am Main 20
Phoenix 20
Atlanta 18
Kunming 18
Shanghai 18
Montreal 17
Warsaw 17
Johannesburg 16
Norwalk 16
Falls Church 15
Bologna 14
Columbus 14
Nanjing 14
Nürnberg 14
San Mateo 14
University Park 14
Brooklyn 13
Brussels 13
Da Nang 13
Guangzhou 13
Haiphong 13
Nuremberg 13
Rio de Janeiro 13
Chennai 12
Hefei 12
Belo Horizonte 11
Saint Petersburg 11
San Francisco 11
Palo Alto 10
Washington 10
Baghdad 9
Kingston 9
North Bergen 9
Porto Alegre 9
Seoul 9
Verona 9
Boston 8
Brno 8
Charlotte 8
Nanchang 8
New Delhi 8
Philadelphia 8
Cleveland 7
Dhaka 7
Hounslow 7
Hải Dương 7
Jakarta 7
Kuala Lumpur 7
Mumbai 7
Redmond 7
Totale 30.774
Salva come PNG Salva come JPEG
Nome #
Awake thoracoscopic biopsy of anterior mediastinal masses 888
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor 593
Enumeration of CD34+ hematopoietic progenitor cells for clinical transplantation: comparison of three different methods 568
Enumeration of CD34+ hematopoietic progenitor cells for clinical transplantation: comparison of three different methods 534
Bowel ultrasonography as an aid for diagnosis of intestinal acute graft-versus-host-disease after allogeneic haematopoietic stem cell transplantation 527
Analysis of the expression of adhesion molecules on CD34+ progenitors from bone marrow, umbilical cord blood and G-CSF mobilized peripheral blood 511
Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation 509
Acute foetal distress and umbilical cord blood banking 508
A phase II study of VP-16, intermediate-dose Ara-C and carboplatin (VAC) in advanced acute myelogenous leukemia and blastic chronic myelogenous leukemia 507
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network. 495
Hematopoietic, Mesenchymal, and Immune Cells Are More Enhanced in Bone Marrow than in Peripheral Blood from Granulocyte Colony-Stimulating Factor Primed Healthy Donors 493
A new system for quality control in hematopoietic progenitor cell units before reinfusion in autologous transplant 489
Randomized comparison of awake nonresectional versus nonawake resectional lung volume reduction surgery. 486
Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation 481
The policy of the Rome Transplant Network (RTN), a metropolitan (2009). The Potential Application Of The Allogeneic Transplant By The Policy Of Widespread Donor Search: An Intention-To-Treat Analysis From The Rome Transplant Network. 476
Cord blood transplantation in adults with acute myeloid leukaemia. 475
A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient 475
Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation 471
The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network 467
Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders 460
Placental/Umbilical cord blood: experience of St. Eugenio Hospital collection center 454
Unrelated Cord Blood transplantaion for children with high risk myelodysplastic syndrome 454
The therapeutic use of cord blood 454
Pre-transplant manipulation processing of umbilical cord blood units: Efficacy of Rubinstein's thawing technique used in 40 transplantation procedures 453
Breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis [6] 450
Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant 450
Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion 450
Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia 443
Outcomes of allogeneic stem cell transplantation for secondary therapy-related acute myeloid leukaemia 439
Allogeneic stem cell transplantation for patients with advanced primary cutaneous T-cell lymphoma 437
Algorithm for donor selection in 2011 435
Red blood cell depletion and cryopreservation of umbilical cord blood (UCB) 434
breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis 433
The Rome Transplant Network model compared to the Italian Bone Marrow Donor Registry activity for unrelated donor search process and transplant efficiency for hematologic malignancy 432
Controversies on antibiotic lock technique duration: experience with a 3-day course for hematological patients 431
Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection 430
A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 428
Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress 428
Impact of Graft-versus-Host Disease Prophylaxis on Outcomes after Myeloablative Single-Unit Umbilical Cord Blood Transplantation 427
Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation 426
Factors Associated with Long-Term Risk of Relapse after Unrelated Cord Blood Transplantation in Children with Acute Lymphoblastic Leukemia in Remission 424
Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies 424
Nonmyeloablative allogeneic blood stem cell transplantation in patients with metastatic solid tumors 423
Reduced intensity allogeneic transplantation in primary cutaneous t-cell lymphomas. 422
Umbilical Cord Blood Transplantation From Unrelated Donors In Patients With Ph-Positive Acute Lymphoblastic Leukemia. 418
Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT. 417
BK virus DNA detection by real-time polymerase chain reaction in clinical specimens 416
Diagnosis of acute foetal distress does not preclude banking of umbilical cord blood units 416
Zoledronic acid-associated thrombotic thrombocytopenic purpura [1] 416
Extracorporeal photochemotherapy in the treatment of acute and chronic GvHD: experience from Rome Transplant Network 411
Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies 411
Quantitative analysis of Fas and bcl-2 expression in hematopoietic precursors 407
The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network. 404
Platelet gel is highly effective in treating muco-cutaneous lesions related to graft-versus-host disease 403
The forkhead box C1 (FOXC1) transcription factor is downregulated in acute promyelocytic leukemia 403
Extracorporeal photopheresis as first-line treatment in high-risk graft-versus-host disease 401
Quality controls of cord blood units according to JACIE standards are highly predictive in unrelated cord blood transplant 393
Fibrin glue directly applied on damaged bladder mucosa during cystoscopy is highly effective to treat severe, refractory, haemorrhagic cystitis after allogeneic transplant 389
Organizzazione e attività delle Banche di sangue placentare 386
CD34-positive cells in human umbilical cord blood express nerve growth factor and its specific receptor TrkA 385
Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders 384
Up-regulation of activating and inhibitory NKG2 receptors in allogeneic and autologous hematopoietic stem cell grafts 384
Allogeneic hematopoietic stem cell transplantation in Primary Cutaneous T Cell Lymphoma 383
Reduced-intensity conditioning combined with standard GvHD prophylaxis is tolerable and highly effective for patients with primary cutaneous T-cell lymphomas undergoing allogeneic transplantation in advanced disease stage. 373
Successful treatment of disseminated fusariosis with high dose liposomal amphotericin-B in a patient with acute lymphoblastic leukemia [4] 373
Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation 372
Identification of the novel allele, HLA-A*02:653, in an Italian patient 369
Analysis of the expression of adhesion molecules on CD34+ progenitors from bone marrow, umbilical cord and G-CSF stimulated peripheral blood 362
Impact of HLA mismatch direction on outcome after umbilical cord blood transplantation for hematological malignant disorders: a retrospective eurocord-EBMT analysis. 360
Il Trapianto di Cellule Stminali Emopoietiche. 351
Access to alternative donor hematopoietic search and transplantation for acute leukemia in different macro-regions of Italy. A GITMO/IBMDR study 337
Unmanipulated bone marrow transplantation from haplo-identical related donor for patients with high-risk haematological malignancies 331
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia after Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey 330
The potential application of the allogeneic transplant according to a widespread donor search policy: an intention-to-treat analysis from the Rome Transplant Network 319
Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update 312
The Potential Application of the Allogeneic Transplant by the Policy of Widespread Donor Search: an Intention- To-Treat Analysis from the Rome Transplant Network . 302
Gemtuzumab ozogamicin in combination with intensive chemotherapy for relapsed/refractory acute myeloid leukemia 300
Umbilical cord blood transplantation in adults with advanced hodgkin's disease: high incidence of post-transplant lymphoproliferative disease 266
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 248
WT1 evaluation in higher-risk myelodysplastic syndrome patients treated with azacitidine 227
Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis 210
Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies 207
Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia 201
Retinoic acid synergizes with the unfolded protein response and oxidative stress to induce cell death in FLT3-ITD+ AML 199
MATCHED-PAIR ANALYSIS OF TRANSPLANT FROM HAPLOIDENTICAL, UNMANIPULATED BONE MARROW DONOR VERSUS HLA IDENTICAL SIBLING FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES 199
Quality assessment of cord blood units selected for unrelated transplantation: a transplant center perspective 189
Cerebellar Neurocysticercosis as Long-Term Complication of Allogeneic Haematopoietic Stem Cell Transplantation from Haploidentical Donor 188
Umbilical cord blood transplantation from unrelated donors in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia 184
Is there still a role for autologous stem cell transplantation for the treatment of acute myeloid leukemia? 173
Is outcome of older people with acute myeloid leukemia improving with new therapeutic approaches and stem cell transplantation? 172
Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation 169
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO) 162
Allelic HLA matching and pair origin are favorable prognostic factors for unrelated hematopoietic stem cell transplantation in neoplastic hematologic diseases: an Italian analysis by the Gruppo italiano trapianto di cellule staminali e terapie cellulari, Italian bone marrow donor registry, and Associazione Italiana di immunogenetica e biologia dei trapianti 119
Incidence of HLA loss in a global multicentric cohort of post-transplantation relapses: results from the Hlaloss Collaborative Study 117
Therapeutic efficiency of platelet gel for the treatment of oral ulcers related to chronic graft versus host disease after allogeneic haematopoietic stem cell transplantation 76
Identification of oral risk factors for chronic graft versus host disease in haematological patients who underwent allogeneic haematopoietic stem cell transplantation 72
Comparative evaluation of biological HLA-DPB1 mismatch models for survival and graft versus host disease prediction after unrelated donor hematopoietic cell transplantation 67
Permissive HLA-DPB1 mismatch and survival after unrelated donor allogeneic stem cell transplantation for hematological malignancies: a comparative analysis of different immunogenetic models on 422 patients from GITMO and IBMDR 66
High resolution donor/recipient HLA matching level in unrelated hematopoietic stem cell transplantation and impact on the transplant outcome: the Italian experience on behalf of GITMO, IBMDR and Aibt 65
Totale 36.888
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.815
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.815
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022750 0 0 0 38 23 67 68 55 49 96 71 283
2022/20231.205 147 106 56 158 73 287 95 75 111 6 65 26
2023/2024447 49 10 26 8 51 131 37 11 14 3 1 106
2024/20251.951 81 428 177 131 48 98 174 106 189 228 127 164
2025/20263.552 252 207 429 331 335 127 464 356 424 342 163 122
2026/20271.290 156 167 697 270 0 0 0 0 0 0 0 0
Totale 36.888